The Nomination Committee's proposal regarding the Board of Humana for the 2023 AGM
Ahead of the Annual General Meeting 2023, The Nomination Committee proposes that the Board of Directors, for the period until the end of the next AGM, shall consist of seven members elected by the Annual General Meeting, without alternates.
Humana's Nomination Committee prior to the 2023 AGM comprises the following members: Fredrik Strömholm, appointed by Impilo Care AB (Chairman of the Nomination Committee), Alexander Kopp, appointed by Incentive AS, Petter Mattsson, appointed by Alcur Fonder, Anette Andersson, appointed by SEB Investment Management AB and Sören Mellstig, Humana's Chairman of the Board.
Since the autumn of 2022, The Nomination Committee has been working to evaluate the work and composition of the Board and, in light of this, identify, interview and evaluate suitable candidates for the future Board, not least in light of the news on 31 January regarding IVO's (the Swedish Health and Social Care Inspectorate) decision to revoke Humana Assistans AB's permit.
The Nomination Committee proposes the re-election of Board members Monica Lingegård, Anders Nyberg and Fredrik Strömholm and the election of Grethe Aasved, Carolina Oscarius Dahl, Leena Munter and Ralph Riber. The Nomination Committee proposes that Anders Nyberg be elected Chairman of the Board, since Sören Mellstig has declined re-election.
Grethe Aasved is a licensed physician from Oslo University, specialised in psychiatry. She has held a number of leading positions in public and private healthcare, as well as the pharmaceutical industry. Grethe is now the managing director of St. Olav's Hospital, the University hospital in Trondheim, with more than 10,000 employees.
Carolina Oscarius Dahl holds a master's degree from the Stockholm School of Economics, and has experience from McKinsey & Company as well as from investment operations at Nordstjernan and Interogo Holding. Carolina is now a partner in Impilo AB.
Leena Munter holds a master's degree in economics from Hanken School of Economics in Helsinki and has since held a number of leading positions in 3M and Manpower, and was from 2014 to 2016 CEO of Mainio Vire, a leading provider of elderly care services in Finland. Between 2017 and 2022, Leena was CEO of Haltija Group, a Finnish group in assistive technology, rehabilitation, service and maintenance services.
Ralph Riber has a bachelor's degree in economics and a master's degree in business administration at the University of Gothenburg. Ralph has significant experience from consulting and senior positions in healthcare and care companies, and was the CEO of Internationella Engelska Skolan 2013-2017. Ralph is on the board of Stockholms Stadsmission.
"We are very pleased that we have succeeded in attracting such strong new members to Humana's Board of Directors, which will contribute to Humana's continued development in several areas, not least in terms of quality and good treatment results in the care that Humana conducts", says Fredrik Strömholm, Chairman of the Nomination Committee.
The Nomination Committee's other proposals for the AGM on May 9, 2023 and the statement on the proposed Board will be found on the company's website www.humanagroup.com in connection with the publication of the notice convening the AGM.
For more information, please contact:
Director of the Board and Chair of the Nomination Committee
076-115 1065, email@example.com
Head of Investor Relations
073-074 79 12, ewelina.Pettersson@humana.se
Humana is a leading Nordic care company providing services within individual and family care, personal assistance, elderly care and special service housing in accordance with LSS. Humana has 18,000 employees in Sweden, Norway, Finland and Denmark providing care for 9,000 individuals and working to achieve the vision “Everyone is entitled to a good life”. In 2021, Humana’s operating revenue was SEK 8,188m. Humana is listed on Nasdaq Stockholm and the company’s headquarters are located in Stockholm. Read more about Humana on: https://www.humanagroup.com/